Comprehensive Review of the Safety and Efficacy of Thymosin Alpha 1 in Human Clinical Trials
Description
CONCLUSIONS: Based on substantial evidence from clinical trials, Tα1 emerges as a well-tolerated and effective immune modulator. The FDA›s restriction appears unfounded, as Tα1 has shown safety and efficacy beyond the initially specified conditions